Veradermics

MANENYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.713 B

$112.80 +5.67%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$70.0M

Loss-making

Shares outstanding

41,780,136

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#56GrifolsGRFS$5.06B
#57Edgewise TherapeuticsEWTX$4.85B
#58VeradermicsMANE$4.71B
#59Acadia PharmaceuticalsACAD$4.55B
#60Parabilis MedicinesPBLS$4.50B

What if Veradermics were worth as much as…

Open the what-if tool →

Gold $30.3T

$724,604.01

Per share 6,424× higher

Bitcoin $1.72T

$41,163.19

Per share 365× higher

Nvidia $5.48T

$131,159.41

Per share 1,163× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Veradermics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.